CytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in London
PRINCETON, N.J., Nov. 9, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that its Chief Executive Officer, Dr. Phillip Chan, and...